Abstract
Galgeun-tang (GGT) is a traditional Korean medication known to have a diaphoretic effect and to improve cerebral circulation. The aim of this study was to investigate the effects of GGT on osteoclast differentiation and bone loss in ovariectomized (OVX) rats compared to Galgeun-tang fermented by Bifidobacterium breve (designated as GFT). GGT significantly and dose-dependently inhibited the receptor activator for nuclear factor κB ligand (RANKL)-induced tartrate-resistant acid phosphatase (TRAP) activity and the formation of multinucleated osteoclasts in RAW264.7 cells. In addition, GGT significantly reduced RANKL-induced mRNA expression levels of TRAP, c-Src, and Cathepsin K. To examine the effect of GGT or GFT in OVX rats, we administered GGT or GFT (15 mL/kg/day) orally to OVX rats for 12 weeks. GGT administration significantly reduced body weight gain in OVX rats. GGT administration also significantly reduced total serum cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, and triglyceride levels in OVX rats. GFT administration significantly reduced serum LDL-cholesterol and triglyceride levels in OVX rats. Moreover, administration of GGT, but not GFT, significantly increased bone mineral density of the femur, which is normally decreased in OVX rats. In conclusion, these results suggest that GGT could have the potential to decrease ovariectomy-induced increases in body weight and lipid content and could prevent bone loss through its inhibitory effect on osteoclast differentiation.
Similar content being viewed by others
References
Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20: 345–357.
Rodan, G. A. and T. J. Martin (2000) Therapeutic approaches to bone diseases. Science 289: 1508–1514.
Teitelbaum, S. L. (2000) Bone resorption by osteoclasts. Science 289: 1504–1508.
Boyle, W. J., W. S. Simonet, and D. L. Lacey (2003) Osteoclast differentiation and activation. Nature 423: 337–342.
Putnam, S. E., A. M. Scutt, K. Bicknell, C. M. Priestley, and E. M. Williamson (2007) Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother. Res. 21: 99–112.
Rechner, A. R., G. Kuhnle, P. Bremner, G. P. Hubbard, K. P. Moore, and C. A. Rice-Evans (2002) The metabolic fate of dietary polyphenols in humans. Free Radic. Biol. Med. 33: 220–235.
Scholz-Ahrens, K. E., P. Ade, B. Marten, P. Weber, W. Timm, Y. Açil, C. C. Glüer, and J. Schrezenmeir (2007) Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J. Nutr. 137: 838–846.
Toda, T., T. Uesugi, K. Hirai, H. Nukaya, K. Tsuji, and H. Ishida (1999) New 6-O-acyl isoflavone glycosides from soybeans fermented with Bacillus subtilis (natto). I. 6-O-succinylated isoflavone glycosides and their preventive effects on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol. Pharm. Bull. 22: 1193–1201.
Chonan, O., K. Matsumoto, and M. Watanuki (1995) Effect of galactooligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats. Biosci. Biotechnol. Biochem. 59: 236–239.
Heo, J. (1984) Donguibogam. pp. 670. Namsadang Press, Seoul, Korea.
Lyu, S. A., S. Y. Lee, S. J. Lee, S. W. Son, M. O. Kim, G. Y. Kim, Y. H. Kim, H. J. Yoon, H. Kim, D. I. Park, and W. S. Ko (2006) Seungma-galgeun-tang attenuates proinflammatory activities through the inhibition of NF-kappaB signal pathway in the BV-2 microglial cells. J. Ethnopharmacol. 107: 59–66.
Shin, J. M., Y. O. Kim, and S. H. Baek (2008) Free radical scavenging activity and kinetic behavior of the Galgeuntang water extract. Orient. Pharm. Exp. Med. 8: 32–38.
Song, J., Q. Han, C. Qiao, Y. Yip, and H. Xu (2007) Simultaneous determination of multiple marker constituents in concentrated Gegen Tang granule by high performance liquid chromatography. Chin. Med. 2: 7.
Hsu, H., D. L. Lacey, C. R. Dunstan, I. Solovyev, A. Colombero, E. Timms, H. L. Tan, G. Elliott, M. J. Kelley, I. Sarosi, L. Wang, X. Z. **a, R. Elliott, L. Chiu, T. Black, S. Scully, C. Capparelli, S. Morony, G. Shimamoto, M. B. Bass, and W. J. Boyle (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Nat. Acad. Sci. 96: 3540–3545.
Kalu, D. N. (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15: 175–191.
Lelovas, P. P., T. T. Xanthos, S. E. Thoma, G. P. Lyritis, and I. A. Dontas (2008) The laboratory rat as an animal model for osteoporosis research. Comp. Med. 58: 424–430.
Rozen, S. and H. J. Skaletsky (2000) Primer3 on the www for general users and for biologist programmers. Methods Mol. Biol. 132: 365–386.
Livak, K. J. and T. D. Schmittgen (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25: 402–408
Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E. F. Wagner, T. W. Mak, T. Kodama, and T. Taniguchi (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell. 3: 889–901.
Ikeda, F., R. Nishimura, T. Matsubara, S. Tanaka, J. Inoue, S. V. Reddy, K. Hata, K. Yamashita, T. Hiraga, T. Watanabe, T. Kukita, K. Yoshioka, A. Rao, and T. Yoneda (2004) Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114: 475–484.
Pang, M., A. F. Martinez, I. Fernandez, W. Balkan, and B. R. Troen (2007) AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells. Gene 15: 151–158.
Halleen, J. M., S. Raisanen, J. J. Salo, S. V. Reddy, G. D. Roodman, T. A. Hentunen, P. P. Lehenkari, H. Kaija, P. Vihko, and H. K. Vaananen (1999) Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J. Biol. Chem. 274: 22907–22910.
Saftig, P., E. Hunziker, V. Everts, S. Jones, A. Boyde, O. Wehmeyer, A. Suter, and K. von Figura (2000) Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice. Adv. Exp. Med. Biol. 477: 293–303.
Soriano, P., C. Montgomery, R. Geske, and A. Bradley (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693–702.
Sung, B., A. Murakami, B. O. Oyajobi, and B. B. Aggarwal (2009) Zerumbone abolishes RANKL-induced NF-kappaB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude mice. Cancer Res. 69: 1477–1484.
Tsuji-Naito, K. (2008) Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation. Bioorg. Med. Chem. 16: 9176–9183.
Qin, L., T. Han, Q. Zhang, D. Cao, H. Nian, K. Rahman, and H. Zheng (2008) Antiosteoporotic chemical constituents from Er-**an Decoction, a traditional Chinese herbal formula. J. Ethnopharmacol. 118: 271–279.
Tsai, H. Y., H. Y. Lin, Y. C. Fong, J. B. Wu, Y. F. Chen, M. Tsuzuki, and C. H. Tang (2008) Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway. Eur. J. Pharmacol. 588: 124–133.
Zhang, Y., X. Zeng, L. Zhang, and X. Zheng (2007) Stimulatory effect of puerarin on bone formation through activation of PI3K/Akt pathway in rat calvaria osteoblasts. Planta Med. 73: 341–347.
Yen, P. H., P. V. Kiem, N. X. Nhiem, N. H. Tung, T. H. Quang, C. V. Minh, J. W. Kim, E. M. Choi, and Y. H. Kim (2007) A new monoterpene glycoside from the roots of Paeonia lactiflora increases the differentiation of osteoblastic MC3T3-E1 cells. Arch. Pharm. Res. 30: 1179–1185.
Aoki, F., S. Honda, H. Kishida, M. Kitano, N. Arai, H. Tanaka, S. Yokota, K. Nakagawa, T. Asakura, Y. Nakai, and T. Mae (2007) Suppression by licorice flavonoids of abdominal fat accumulation and body weight gain in high-fat diet-induced obese C57BL/ 6J mice. Biosci. Biotechnol. Biochem. 71: 206–214.
Wang, J. F., Y. X. Guo, J. Z. Niu, J. Liu, L. Q. Wang, and P. H. Li (2004) Effects of Radix Puerariae flavones on liver lipid metabolism in ovariectomized rats. World J. Gastroenterol. 10: 1967–1970.
Martin, P. M., K. B. Horwitz, D. S. Ryan, and W. L. McGuire (1978) Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinol. 103: 1860–1867.
Bolego, C., A. Poli, A. Cignarella, and R. Paoletti (2003) Phytoestrogens: Pharmacological and therapeutic perspectives. Curr. Drug Targets 4: 77–87.
Author information
Authors and Affiliations
Corresponding author
Additional information
Both authors contributed equally to this study.
Rights and permissions
About this article
Cite this article
Shim, KS., Park, H., Lee, JH. et al. Inhibitory effect of Galgeun-tang on RANKL-induced osteoclast differentiation and bone loss in ovariectomized rats. Biotechnol Bioproc E 16, 158–166 (2011). https://doi.org/10.1007/s12257-010-0178-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-010-0178-9